Oxford Nanopore Technologies raises £31.4m in new funding

Oxford Nanopore Technologies has raised £31.4m in new funding via a private placement of ordinary shares in the company.

The privately held company is said to be developing a disruptive technology for the real-time electronic analysis of single molecules.

Dr Gordon Sanghera, chief executive officer of Oxford Nanopore, said: ‘This round of funding, nearly all of which comes from existing investors, will support a range of corporate development activities, including the development of our commercial infrastructure, expansion of our manufacturing function and further research and development for our DNA/RNA sequencing and protein/miRNA analysis applications.

‘We will also continue to maintain our leadership position in nanopore innovation through maintenance and expansion of our broad intellectual property portfolio.’